Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sensorion
< Previous
1
2
3
Next >
Sensorion Announces its Participation in the 31st Annual Congress of the European Society of Gene and Cell Therapy and the Presentation of Several Posters on GJB2-GT
October 17, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Webconference for Retail Shareholders on October 10, 2024
September 26, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of its Half Year 2024 Report
September 23, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology
September 23, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs at the World Congress of Audiology in Paris
September 20, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports 2024 First Half Results and Highlights Recent Updates
September 18, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop
September 12, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the World Congress of Audiology in September 2024 in Paris and will Lead a Symposium on Medical Advances in the Field of Hearing Loss
September 02, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in Stifel's Biotech Summer Summit
August 05, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Positive Recommendation From the Data Safety Monitoring Board (DSMB) Regarding the Continuation of NOTOXIS, its Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
July 23, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss
July 15, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer
June 27, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
June 20, 2024
From
Sensorion
Via
Business Wire
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
May 30, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024
May 28, 2024
From
Sensorion
Via
Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 29, 2024
May 07, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
April 26, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference
April 10, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
April 08, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of Its Letter to Shareholders
March 21, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe
March 15, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of its Financial Report for 2023
March 14, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports Full-Year 2023 Financial Results and Business Update
March 14, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation
March 11, 2024
From
Sensorion
Via
Business Wire
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results
March 06, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference
February 29, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces a €50.5 Million Financing With Participation From New and Existing US and European Healthcare Specialist Investors
February 09, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation
February 01, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting
January 29, 2024
From
Sensorion
Via
Business Wire
Sensorion Appoints Dr. Federico Mingozzi as Non-Executive Director to the Board of Directors
January 25, 2024
From
Sensorion
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.